TENNOR THERAP-B (ASX: 06872) has announced the appointment of Dr. Song Gaoguang, a non-executive director, to the board's Compensation and Assessment Committee.
His term on the committee is effective from June 8, 2026, and will continue until the conclusion of the current board's inaugural term.